GlowSlim Patient Information
What our Clients Say About GlowSlim?
What is Semaglutide?
What is Tirzepatide
Youtube
Semaglutide Vs Tirzepatide, which is better?
Semaglutide and tirzepatide are both injectable medications used to help manage type 2 diabetes and aid in weight loss, but they work in different ways. Semaglutide is a type of medication that acts like a natural hormone in the body to help control blood sugar, increase insulin production, and slow down digestion. Tirzepatide, however, works on two different hormones in the body—one like semaglutide, and another that helps regulate insulin and feelings of hunger. This gives tirzepatide a stronger effect on lowering blood sugar and promoting weight loss than semaglutide, although both medications are effective for managing diabetes and helping with weight loss. For reference, Semaglutide typically yields weight loss of 15-20% of body weight in a year, while Tirzepatide is 20-30% in a year, both at maximum doses.
GLP-1 FAQs (Frequently Asked Questions)
1. What is GLP-1? A: GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone in the body that helps regulate blood sugar levels by stimulating insulin secretion, slowing stomach emptying, and reducing appetite. Synthetic versions (GLP-1 receptor agonists) are used to treat type 2 diabetes and obesity. 2. How do GLP-1 medications work? A: GLP-1 receptor agonists mimic the natural GLP-1 hormone, helping to: Increase insulin release (lowers blood sugar) Reduce glucagon secretion (prevents liver from releasing excess glucose) Slow digestion (promotes fullness and weight loss) Decrease appetite 3. What conditions are GLP-1 medications used for? A: They are FDA-approved for: Type 2 diabetes (e.g., Ozempic, Trulicity, Victoza) Obesity/weight management (e.g., Wegovy, Saxenda, Zepbound) Some may also reduce cardiovascular risks in certain patients. 4. What are common GLP-1 medications? A: Examples include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Tirzepatide (Mounjaro, Zepbound) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) 5. How are GLP-1 medications administered? A: Most are injectable (once daily or weekly), though Rybelsus (semaglutide) is an oral tablet. 6. What are the common side effects? A: Most are mild and improve over time: Nausea, vomiting, diarrhea Constipation, stomach pain Headache, dizziness Low blood sugar (if taken with insulin or sulfonylureas) 7. Do GLP-1 medications cause weight loss? A: Yes—they slow digestion and reduce hunger, leading to significant weight loss in many patients (e.g., Wegovy and Zepbound are approved specifically for obesity). 8. Are GLP-1 medications safe for long-term use? A: Studies support long-term safety for diabetes and weight management, but potential risks (e.g., pancreatitis, gallbladder issues, thyroid tumors in rodents) require monitoring. 9. Can GLP-1 medications be used with other diabetes drugs? A: Yes, but combining them with insulin or sulfonylureas may increase hypoglycemia risk—dose adjustments may be needed. 10. Who should avoid GLP-1 medications? A: They are not recommended for: Type 1 diabetes (unless prescribed off-label with insulin) History of medullary thyroid cancer or MEN-2 syndrome Severe gastrointestinal diseases Pregnancy (limited data; consult a doctor) 11. How long does it take to see results? A: Blood sugar improvements may occur within weeks, while weight loss effects typically show after several months. 12. Do GLP-1 medications cure diabetes or obesity? A: No—they help manage conditions but require ongoing use for sustained benefits. Lifestyle changes (diet, exercise) are still essential. 13. Are GLP-1 medications covered by insurance? A: Coverage varies; many plans cover them for diabetes, but weight-loss versions (e.g., Wegovy, Zepbound) may require prior authorization. 14. Can GLP-1 medications be stopped suddenly? A: Sudden discontinuation is not dangerous, but blood sugar and weight may rebound. Tapering under medical supervision is advised. 15. Are there alternatives to GLP-1 medications? A: Yes, including: SGLT-2 inhibitors (e.g., Jardiance) Metformin (first-line for type 2 diabetes) Lifestyle interventions (diet, exercise, bariatric surgery)
Client Information
Are you a new or Existing Client of the Clinic?
New Client
Old Client
Consultations Required for First-Time Clients Select Online or at the Clinic
Clinic
Online
Name
First Name
Last Name
Email
example@example.com
Phone Number
-
Area Code
Phone Number
Please Provide Your Address (For Delivery Purposes Only)
Street Address
Street Address Line 2
City
State / Province
Postal / Zip Code
Doctor's Consultation Appointment (Schedule is Subject to Availability, Consult is 1,000.00 can be paid before the appointment schedule, as well as can be paid via online channels)
Upload Transaction Confirmation
Browse Files
Drag and drop files here
Choose a file
Consultations are confirmed once payment has been received, please note that consultation time is subject to availability. Glowzone Wellness Hub Staff will coordinate with you via phone or email for confirmation of your clinic or in person appointment.
Cancel
of
Have you been diagnosed with any of the following conditions? (Check all that apply)
Diabetes
Hypertension
Thyroid Conditions
Kidney Conditions
Liver disease
Pancreatitis
Gallbladder disease
Cancer
Are you pregnant, breastfeeding, or planning to become pregnant
Yes
No
What are your primary goals for using Semaglutide or Tirzepatide? (Check all that apply)
Weight loss
Improved blood sugar control
Prevention of diabetes complications
Others
Have you previously used any weight-loss or diabetes medications
Yes
No
Consent and Acknowledgment
By Signing this waiver form, I, the undersigned, acknowledge and confirm the following: Purpose and Nature of Treatment I have chosen to undergo compounded semaglutide/tirzepatide therapy as part of my weight management plan. I understand that this therapy is intended to assist with appetite suppression, blood sugar regulation, and weight loss. Compounded Medication I acknowledge that the semaglutide provided is a compounded medication prepared by a compounding pharmacy. I understand that compounded medications are not FDA-approved but are customized based on medical needs. Risks and Side Effects I have been informed of potential risks and side effects, which may include but are not limited to: Nausea, vomiting, or diarrhea. Constipation, bloating, or abdominal discomfort. Hypoglycemia (low blood sugar), especially if combined with other glucose-lowering medications. Rare but serious risks, such as pancreatitis or thyroid tumors (as observed in animal studies). I will promptly inform Glowzone Wellness Hub of any adverse effects. Medical History Disclosure I have disclosed my full medical history, including any conditions such as: Type 1 or Type 2 diabetes. Thyroid disorders or a family history of medullary thyroid carcinoma. Kidney or liver disease. Gastrointestinal disorders or allergies. I acknowledge that failure to disclose relevant medical history could increase my risk of complications. Responsibility for Lifestyle Changes I understand that compounded semaglutide/tirzepatide is most effective when combined with a healthy diet, regular exercise, and lifestyle changes. I am committed to following the recommendations provided by Glowzone Wellness Hub. Monitoring and Follow-Up I agree to attend scheduled follow-ups and monitoring sessions to evaluate my progress and adjust the treatment plan if necessary. No Guarantees of Outcome I understand individual results may vary, and weight loss is not guaranteed. Glowzone Wellness Hub and its healthcare providers have made no promises or guarantees regarding the extent of weight loss or duration of results. Financial Responsibility I accept full financial responsibility for the cost of the therapy, including consultation fees, compounded medication, and any follow-up appointments. I understand that this treatment is elective and may not be covered by insurance. Release of Liability I release Glowzone Wellness Hub, its healthcare providers, and staff from any liabilities related to this therapy, except in cases of gross negligence or misconduct. I understand that I am undertaking this treatment voluntarily and assume full responsibility for any risks involved. Consent for Treatment By signing this form: I confirm that I have read and fully understood the information provided. I have had the opportunity to ask questions, and all of my concerns have been addressed. I voluntarily consent to compounded semaglutide therapy with Glowzone Wellness Hub.
DATA PRIVACY NOTICE
Compliant with the Data Privacy Act of 2012 (Republic Act No. 10173) At Glowzone Wellness Hub, we are committed to protecting your privacy and ensuring the security of your personal data. This notice explains how we collect, use, store, and disclose your information in compliance with the Data Privacy Act of the Philippines (DPA). 1. Collection of Personal Data We may collect the following personal information from you: Basic details (e.g., name, age, gender, contact information) Health and wellness records (e.g., medical history, treatment plans, therapy notes) Payment and transaction details (e.g., billing information, insurance details) Other relevant data for service improvement (e.g., feedback, survey responses) 2. Purpose of Data Processing Your personal data is collected and processed for: Providing wellness and healthcare services Managing appointments and records Processing payments and insurance claims Improving our services and customer experience Compliance with legal and regulatory requirements 3. Storage and Protection We implement appropriate security measures (technical, physical, and organizational) to safeguard your data against unauthorized access, alteration, or disclosure. Your records are stored securely and retained only as long as necessary or as required by law. 4. Disclosure and Sharing of Data Your personal data may be shared only when necessary with: Accredited healthcare providers involved in your treatment Authorized third-party service providers (e.g., payment processors, IT support) Government agencies, if required by law (e.g., health regulations, legal orders) We do not sell or lease your personal information to third parties for marketing purposes. 5. Your Rights Under the Data Privacy Act As a data subject, you have the right to: Access your personal data in our records Correct or update inaccurate information Request deletion of data, where permissible by law Withdraw consent for processing (may affect service delivery) File a complaint with the National Privacy Commission (NPC) if your rights are violated
Affix Your Signature Here
*
Continue
Continue
Should be Empty: